Am.  Jour.  Pharm.  \ 
March,  1914.  J 
Progress  in  Pharmacy. 
133 
"  At  the  sign  of  '  Ye  wild  man/  "  a  reproduction  of  Liebig's 
laboratory  at  Giessen,  and  the  interior  of  an  Italian  pharmacy  of 
the  1 6th  Century. — Pharm.  J.,  191 3,  v.  91,  pp.  944-945. 
History  of  Pharmacy. — The  Chemist  and  Druggist,  January  31, 
1 9 14,  v.  84,  p.  183,  announces  that  an  arrangement  has  been  made 
with  the  publishers  of  the  "  Chronicles  of  Pharmacy,"  by  the  late 
A.  C.  Wooton,  which  enables  that  journal  to  offer  this  book  in  two 
volumes  at  7s.  6d.,  carriage  paid  in  the  United  Kingdom,  or  8's.  post 
free  to  any  part  abroad.  This  exceptional  offer  should  popularize 
the  book  and  make  it  available  to  all  pharmacists  who  are  in  any 
way  interested  in  the  history  of  their  craft.  Orders  for  the  volumes 
should  be  addressed  to  the  book  department  of  the  Chemist  and  Drug- 
gist, 42  Cannon  Street,  London,  E.  C. 
Friedmann  Institutes  are  being  organized  in  various  parts  of 
the  country  and  the  personnel  of  these  organizations  in  practically 
every  instance  is  sufficient  to  suggest  their  true  nature.  Steps  have 
been  taken  in  several  states  to  check  this  exploitation  of  the  consump- 
tive for  commercial  gain.  But  what  is  most  needed  is  that  these 
unscrupulous  attempts  should  be  met  with  an  intensive  campaign 
of  education  of  the  public  concerning  the  dangers  and  worthlessness 
of  this  treatment. — /.  Am.  M.  Assoc.,  1913,  v.  61,  p.  1050. 
U.  S.  Patent  for  a  Complex  Medicine. — An  editorial  calls  at- 
tention to  U.  S.  Patent  1,081,069,  granted  December  9,  191 3,  for  a 
mixture  of  excretory  constituents — creatinin,  guanidin,  and  allan- 
toin — to  be  used  as  a  specific  in  a  number  of  microbial  infections 
and  illnesses.  The  editorial  states  that  the  granting  of  a  patent  on 
the  claims  made  should  be  sufficient  to  show  the  need  of  change  in 
the  method  of  granting  patents,  at  least  in  the  methods  governing 
the  issuance  of  patents  for  medicinal  products. — /.  Am.  M.  Assoc., 
1914,  v.  62,  pp.  54-55. 
Aloes. — Tutin  and  Naunton  report  an  investigation  to  ascertain 
if  any  anthraquinone  derivative  other  than  aloe-emodin  is  contained 
in  aloes.  They  were  unable  to  isolate  such  compounds  as  emodin 
and  chrysophanol  but  found  several  samples  of  aloes  which  contained 
aloe-emodin  as  an  impurity. — Pharm.  J.,  1913,  v.  91,  p.  836. 
Alypin,  Misleading  Advertisement  of. — Bruck,  F.,  called  at- 
tention four  years  ago  to  the  misleading  statements  in  the  advertising 
of  alypin.  Both  an  anaesthetic  and  blood-expelling  action  are  claimed 
for  it  but  in  reality  it  has  none  of  the  latter.  It  is  also  stated  that 
alypin  is  considerably  less  toxic  than  cocaine,  while  Schroder  and 
